Доступ предоставлен для: Guest
Портал Begell Электронная Бибилиотека e-Книги Журналы Справочники и Сборники статей Коллекции
Critical Reviews™ in Immunology
Импакт фактор: 1.352 5-летний Импакт фактор: 3.347 SJR: 1.022 SNIP: 0.55 CiteScore™: 2.19

ISSN Печать: 1040-8401
ISSN Онлайн: 2162-6472

Выпуски:
Том 39, 2019 Том 38, 2018 Том 37, 2017 Том 36, 2016 Том 35, 2015 Том 34, 2014 Том 33, 2013 Том 32, 2012 Том 31, 2011 Том 30, 2010 Том 29, 2009 Том 28, 2008 Том 27, 2007 Том 26, 2006 Том 25, 2005 Том 24, 2004 Том 23, 2003 Том 22, 2002 Том 21, 2001 Том 20, 2000 Том 19, 1999 Том 18, 1998 Том 17, 1997 Том 16, 1996 Том 15, 1995 Том 14, 1994

Critical Reviews™ in Immunology

Купить выпуск $264.00 Том 18, 1998 Выпуск 1-2

DOI: 10.1615/CritRevImmunol.v18.i1-2

Содержание:

PREFACE
M. Zouhair Atassi
vi pages
DOI: 10.1615/CritRevImmunol.v18.i1-2.10
T Cell Immunity to Tumor Antigens
Ingegerd Hellstrom , Karl Erik Hellstrom
pages 1-6
DOI: 10.1615/CritRevImmunol.v18.i1-2.20
Identification of Peptides for Immunotherapy of Cancer. It is Still Worth the Effort
Markwin P. Velders, John D. Nieland, Michael P. Rudolf, Kathleen Loviscek, Sanne Weijzen, Earin E. de Visser, M. Fatima Macedo, Michele Carbone, W. Martin Kast
pages 7-27
DOI: 10.1615/CritRevImmunol.v18.i1-2.30
p53-Based Immunotherapy of Cancer
Albert B. DeLeo
pages 29-35
DOI: 10.1615/CritRevImmunol.v18.i1-2.40
HER-2/neu Oncogenic Protein: Issues in Vaccine Development
Mary L. Disis, Martin A. Cheever
pages 37-45
DOI: 10.1615/CritRevImmunol.v18.i1-2.50
Strategies for Tumor Elimination by Cytotoxic T Lymphocytes
Linda A. Sherman, Matthias Theobald, David Morgan, Javier Hernandez, Igor Bacik, Jonathan Yewdell, Jack Bennink, Judith Biggs
pages 47-54
DOI: 10.1615/CritRevImmunol.v18.i1-2.60
Recognition of Melanoma-Derived Antigens by CTL: Possible Mechanisms Involved in Down-Regulating Anti-Tumor T-Cell Reactivity
Licia Rivoltini, Douglas J. Loftus, Paola Squarcina, Chiara Castelli, Francesca Rini, Flavio Arienti, Filiberto Belli, Francesco M. Marincola, Carsten Geisler, Alessandro Borsatti, Ettore Appella, Giorgio Parmiani
pages 55-63
DOI: 10.1615/CritRevImmunol.v18.i1-2.70
In Vitro Immunization and Expansion of Antigen-Specific Cytotoxic T Lymphocytes for Adoptive Immunotherapy Using Peptide-Pulsed Dendritic Cells
Van Tsai, Ichiro Kawashima, Elissa Keogh, Kieran Daly, Alessandro Sette, Esteban Celis
pages 65-75
DOI: 10.1615/CritRevImmunol.v18.i1-2.80
Tumor-Specific Immune Response: Current In Vitro Analyses May Not Reflect the In Vivo Immune Status
Florence Faure, Jos Even, Philippe Kourilsky
pages 77-86
DOI: 10.1615/CritRevImmunol.v18.i1-2.90
Dendritic Cells, Interleukin 12, and CD4+ Lymphocytes in the Initiation of Class l-restricted Reactivity to a Tumor/Self Peptide
Ursula Grohmann, Maria Cristina Fioretti, Roberta Bianchi, Maria Laura Belladonna, Emira Ayroldi, Daniela Surace, Silvia Silla, Paolo Puccetti
pages 87-98
DOI: 10.1615/CritRevImmunol.v18.i1-2.100
Dendritic Cell-Based Immunotherapy of Prostate Cancer
M. L. Salgaller, B. A. Tjoa, P. A. Lodge, H. Ragde, G. Kenny, A. Boynton, G. P. Murphy
pages 109-119
DOI: 10.1615/CritRevImmunol.v18.i1-2.120
Human Leukemia-derived Dendritic Cells: Ex-vivo Development of Specific Antileukemic Cytotoxicity
Aniruddha Choudhury, Antoine Toubert, Sapna Sutaria, Dominique Charron, Richard E. Champlin, David F. Claxton
pages 121-131
DOI: 10.1615/CritRevImmunol.v18.i1-2.130
Immunotherapy of Colon Cancer Using Chimeric mAb 31.1
Myron Arlen, Al Tsang, Tommy Wang
pages 133-138
DOI: 10.1615/CritRevImmunol.v18.i1-2.140
Tumor Cell Recognition by Lymphocytes: Is the MHC Always Essential?
Beverly Z. Packard , Akira Komoriya
pages 139-144
DOI: 10.1615/CritRevImmunol.v18.i1-2.150
TRANSCRIPT OF OPEN DISCUSSION
pages 145-152
DOI: 10.1615/CritRevImmunol.v18.i1-2.160

Critical Reviews™ in Immunology

Model for the recruitment of inducer-specific TNF-α gene enhanceosome in T lymphocytes., Vol. 29, Iss.2, Viral Mechanisms Involved in the TranscriptionalCBP/p300 Regulation of Inflammat..... Model for the recruitment of inducer-specific TNF-α gene enhanceosome in T lymphocytes., Vol. 29, Iss.2, Viral Mechanisms Involved in the TranscriptionalCBP/p300 Regulation of Inflammat..... Viral Mechanisms Involved in the Transcriptional CBP/р300 Regulation of Inflammatory and Immune Responses
Activation of several B cells is necessary for exosome release.Vol. 29, Iss. 3, Exosome Release by Primary B Cells. Activation of several B cells is necessary for exosome release.Vol. 29, Iss. 3, Exosome Release by Primary B Cells. Exosome Release by Primary B Cells
Homology model of human GrM. Vol. 29, Iss. 4, The Biology of Granzyme M: A Serine Protease with Unique Features. Homology model of human GrM. Vol. 29, Iss. 4, The Biology of Granzyme M: A Serine Protease with Unique Features. Biology of Granzyme M: A Serine Protease with Unique Features
(A) Gap-junction formation, (B) A three-dimensional collagen matrix Vol. 30, Iss. 6, Endothelial Cells as Key Determinants of the Tumor Microenvironment. (A) Gap-junction formation, (B) A three-dimensional collagen matrix Vol. 30, Iss. 6, Endothelial Cells as Key Determinants of the Tumor Microenvironment. Endothelial Cells as Key Determinants of the Tumor Microenvironment: Interaction with Tumor Cells, Extracellular Matrix and Immune Killer Cells
Biphasic HCV RNA decline after IFN treatment of chronic hepatitis C. Vol. 30, Iss. 2, Treatment of Hepatitis C Virus Infection with Interferon and Small Molecule Direct Antivirals. Biphasic HCV RNA decline after IFN treatment of chronic hepatitis C. Vol. 30,  Iss. 2, Treatment of Hepatitis C Virus Infection with Interferon and Small Molecule Direct Antivirals. Treatment of Hepatitis C Virus Infection With Interferon and Small Molecule Direct Antivirals: Viral Kinetics and Modeling